Navitor Pharmaceuticals to Develop NV-5138, a Specific Activator of mTORC1 for Treatment-Resistant Depression, Based on Promising Data Presented at Society for Neuroscience 2017
Read More
Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to Neutrolis, Remora Therapeutics
Read More
Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients’ Lives
Read More
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Cocoon Biotech Appoints Dr. Annalisa Jenkins as…
Read More
Tissue Modeling May Cut Clinical Trial Time
Read More
Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products
Read More
Amgen Teams Up With Cambridge Biotech Community To Select Two Startups To Receive Golden Tickets At LabCentral
Read More
Affinivax $6.99 million Fundraising. Steven Brugger Released Jan 5 SEC form
Read More
Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs
Read More
LabCentral Gallery 1832 Features Large-Scale, Neo-Expressionist, Figurative Work by Boston-Area Artist, Sorin Bica
Read More
